La N-acetilcisteína reduce el progreso de daño cardíaco en modelos experimentales.
N-acetylcysteine is known in a number of medical specialties and its ability to decrease the impact of reperfusion injury in acute myocardial infarction has boosted its use in cardiology over the past decades. N-acetylcysteine has a farreaching range of effects since it functions as a protective age...
| Published in: | CorSalud Vol. 12; no. 2; pp. 214 - 219 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Published: |
Cardiocentro Ernesto Che Guevara
Apr-Jun2020
|
| Online Access: | View this record in EBSCOhost |